Anti-chemotactic activity of capsular polysaccharide of Cryptococcus neoformans in vitro

Microbiology and Immunology

Volumn 41, Issue 9, 1997, Pages 657-664

  Fujihara, Hitomi ^a,b   Kagaya, Keiko ^a,b   Fukazawa, Yoshimura ^a,b  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b Yamanashi Institute of Biomedical Research   (Japan)

Author keywords

Alternative complement pathway; Capsular polysaccharide; Chemo tactic factor; Chemotaxis; Cryptococcus neoformans; O acetyl group

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIUM LIPOPOLYSACCHARIDE; CHEMOTACTIC FACTOR; ZYMOSAN;

ACETYLATION; ARTICLE; BACTERIAL CELL WALL; BACTERIAL MEMBRANE; BACTERIUM ISOLATION; CHEMOTAXIS; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; CRYPTOCOCCUS NEOFORMANS; DOSE RESPONSE; EXTRACELLULAR SPACE; INFLAMMATION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE;

BACTERIA (MICROORGANISMS); FILOBASIDIELLA NEOFORMANS; MURINAE;

EID: 0030922860     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1997.tb01908.x     Document Type: Article

References (32)

1. Chenoweth, D.E. 1986. Complement mediators of inflammation, p. 63-86. In Ross, G.D. (ed), Immunobiology of the complement system, Academic Press, Inc., New York.
2. Cherniak, R. 1987. Soluble polysaccharides of Cryptococcus neoformans, p. 40-54. In McGinnis, M.R. (ed), Current topics in medical mycology, vol. 2, Springer-Verlag, New York.
3. Diamond, R.D., and Erickson, N.F., III. 1982. Chemotaxis of human neutrophils and monocytes induced by Cryptococcus neoformans. Infect. Immun. 38: 380-382.
4. Dong, Z.M., and Murphy, J.W. 1995. Intravascular cryptococcal culture filtrate (CneF) and its major component, glucuronoxylomannan, are potent inhibitors of leukocyte accumulation. Infect. Immun. 63: 770-778.
5. Dublis, M., Gillis, K.A., Hamilton, J.K., Reber, P.A., and Smith, F. 1956. Colorimetric method for determination of sugars and related substances. Anal. Chem. 28: 350-356.
6. Falk, W., Goodwin, R.H., and Leonard, E.J. 1980. A 48-well microchemotaxis assembly for rapid and accurate measurement of leukocyte migration. J. Immunol. Methods 33: 239-247.
7. Farmer, S.D., and Komorowski, R.A. 1973. Histologic response to capsule-deficient Cryptococcus neoformans. Arch. Pathol. 96: 383-387.
8. Fazekas, G., and Schwarz, J. 1958. Histology of experimental murine cryptococcosis. Am. J. Pathol. 34: 517-529.
9. Fernandez, H.N., Henson, P.M., Otanis, A., and Hugli, T.E. 1978. Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under simulated in vivo conditions. J. Immunol. 120: 109-115.
10. Ikeda, R., Nishikawa, A., Shinoda, T., and Fukazawa, Y. 1985. Chemical characterization of capsular polysaccharide from Cryptococcus neoformans serotype A-D. Microbiol. Immunol. 29: 981-991.
11. Ikeda, R., Shinoda, T., Kagaya, K., and Fukazawa, Y. 1984. Role of serum factors in the phagocytosis of weakly or heavily encapsulated Cryptococcus neoformans strains by guinea pig peripheral blood leukocytes. Microbiol. Immunol. 28: 51-61.
12. Kagaya, K., Yamada, T., Miyakawa, Y., Fukazawa, Y., and Saito, S. 1985. Characterization of pathogenic constituents of Cryptococcus neoformans strains. Microbiol. Immunol. 29: 517-532.
13. Kozel, T.R., and Cazin, J., Jr. 1971. Nonencapsulated variant of Cryptococcus neoformans. I. Virulence studies and characterization of soluble polysaccharide. Infect. Immun. 3: 287-294.
14. Kozel, T.R., and Gotschlich, E.G. 1982. The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. J. Immunol. 129: 1675-1680.
15. Kozel, T.R., Highison, B., and Statton, C.J. 1984. Localization on encapsulated Cryptococcus neoformans of serum components opsonic for phagocytosis by macrophages and neutrophils. Infect. Immun. 43: 574-579.
16. Kozel, T.R., Pfrommer, G.S.T., Guerlain, A.S., Highison, B.A., and Highison, G.J. 1988. Strain variation in phagocytosis of Cryptococcus neoformans: dissociation of susceptibility to phagocytosis from activation and binding of opsonic fragments of C3. Infect. Immun. 56: 2794-2800.
17. Kozel, T.R., Wilson, M.A., and Murphy, J.W. 1991. Early events in initiation of alternative complement pathway activation by the capsule of Cryptococcus neoformans. Infect. Immun. 59: 3101-3110.
18. Kozel, T.R., Wilson, M.A., Pfrommer, G.S.T., and Schlageter, A.M. 1989. Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins. Infect. Immun. 57: 1922-1927.
19. Law, S.-K.A., Minich, A.M., and Levine, R.P. 1981. Binding reaction between the third human complement protein and small molecules. Biochemistry 20: 7457-7463.
20. Laxalt, K.A., and Kozel, T.R. 1979. Chemotaxigenesis and activation of the alternative complement pathway by encapsulated and non-encapsulated Cryptococcus neoformans. Infect. Immun. 26: 435-440.
21. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
22. Polhill, R.B., Jr., Pruitt, K.M., and Johnston, R.B., Jr. 1978. Kinetic assessment of alternative complement pathway activity in a hemolytic system. I. Experimental and mathematical analyses. J. Immunol. 121: 363-370.
23. Rhodes, J., Wicker, L.S., and Urba, W.J. 1980. Genetic control of susceptibility to Cryptococcus neoformans in mice. Infect. Immun. 29: 494-499.
24. Sadamoto, A., Ikeda, R., Nishikawa, A., and Shinoda, T. 1993. Evidence for interference by immune complexes in the serodiagnosis of cryptococcosis. Microbiol. Immunol. 37: 129-133.
25. Truelsen, K., Young, T., and Kozel, T.R. 1992. In vivo complement activation and binding of C3 to encapsulated Cryptococcus neoformans. Infect. Immun. 60: 3937-3939.
26. Wagner, J.L., and Hugli, T.E. 1984. Radioimmunoassay for anaphylatoxins: a sensitive method for determining complement activation products in biological fluids. Anal. Biochem. 136: 75-88.
27. Washburn, R.G., Bryant-Varela, B.J., Julian, N.C., and Bennett, J.E. 1991. Differences in Cryptococcus neoformans capsular polysaccharide structure influence assembly of alternative complement pathway C3 convertase on fungal surfaces. Mol. Immunol. 28: 465-470.
28. Watabe, T., Miyaji, M., and Nishimura, K. 1984. Studies on relationship between cysts and granulomas in murine cryptococcosis. Mycopathologia 86: 113-120.
29. Wexler, D.E., Nelson, R.D., and Cleary, P.P. 1983. Human neutrophil chemotactic response to Group A streptococci: bacteria-mediated interference with complement-derived chemotactic factors. Infect. Immun. 39: 239-246.
30. Wilkinson, P.C., and Lackie, J.M. 1979. The adhesion, migration, and chemotaxis of leukocytes in inflammation. Curr. Top. Pathol. 68: 47-88.
31. Wilson, M.A., and Kozel, T.R. 1992. Contribution of anti-body in normal human serum to early deposition of C3 onto encapsulated and nonencapsulated Cryptococcus neoformans. Infect. Immun. 60: 754-761.
32. Young, B.J., and Kozel, T.R. 1993. Effects of strain variation, serotype, and structural modification on kinetics for activation and binding of C3 to Cryptococcus neoformans. Infect. Immun. 61: 2966-2972.